New cancer clinical trial: A Study to Investigate the Efficacy and Safety of Eribulin in Korean Breast Cancer Participants

Published on: February 19, 2018 at 12:00PM
Condition:   Locally Advanced or Metastatic Breast Cancer
Intervention:   Drug: Eribulin mesylate
Sponsor:   Eisai Korea Inc.
Recruiting
http://ift.tt/2FgbY2V